AI assistant
EQTEC PLC — Regulatory Filings 2026
May 8, 2026
7628_bfr_2026-05-08_b9e186c5-339a-4867-9ce4-f0b6bb443efe.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 5834D
FORGENT PLC
08 May 2026
8 May 2026
Forgent plc
("Forgent" or the "Company")
Green Rock Copper Gold Project : Maiden Field Programme Completion
Forgent plc (AIM: FORG), the technology-led energy transition company, announces the completion of its maiden field programme at the Green Rock Project, during which 111 rock chip samples were collected and submitted to ALS Laboratories in Perth for multi-element assay, including copper and gold analysis.
As previously announced, the programme comprised an initial site visit and systematic rock chip sampling across the project area. The collected samples are now undergoing laboratory analysis, with assay results expected within approximately four weeks.
The Company will provide further updates as appropriate following receipt and interpretation of the assay results.
For further information on Forgent plc, visit the Company's website www.forgentplc.com or contact:
ENQUIRIES
| FORGENT plc James Parsons |
[email protected] |
| Strand Hanson - Nomad & Financial Adviser James Harris / Richard Johnson |
+44 20 7409 3494 |
| Global Investment Strategy UK Ltd - Broker Christopher Kipling Samantha Esqulant |
+44 20 7048 9045 |

Figure 1: Forgent Plc West Australian project location map.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDZZGGKKRZGVZG